Mixed Analyst Calls Hit Biotech: Downgrades for Bristol Myers and uniQure, Upgrades for Rezolute and Zentalis

Leerink cut Bristol Myers and raised Zentalis. Barclays lowered uniQure. Cantor upgraded Rezolute. New Buy calls on Ovid, Maravai, and Regenxbio.